Premium
Game of isoforms: PI 3K β ‐sparing inhibitor is coming
Author(s) -
Cheng Hanyin,
Aplin Andrew E.
Publication year - 2015
Publication title -
pigment cell and melanoma research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.618
H-Index - 105
eISSN - 1755-148X
pISSN - 1755-1471
DOI - 10.1111/pcmr.12350
Subject(s) - p110α , pten , pi3k/akt/mtor pathway , phosphoinositide 3 kinase , melanoma , cancer research , mek inhibitor , gene isoform , mutant , protein subunit , targeted therapy , suppressor , biology , kinase , mapk/erk pathway , chemistry , signal transduction , cancer , microbiology and biotechnology , gene , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom